The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses

Last updated: May 16, 2022
Sponsor: University of British Columbia
Overall Status: Completed

Phase

N/A

Condition

Bone Diseases

Bone Neoplasm

Treatment

N/A

Clinical Study ID

NCT00474448
H07-00457
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to assess the health-related quality of life of subjects who have Hereditary Multiple Exostoses and to develop a disease specific quality of life survey. The investigators hypothesize that there are a wide range of quality of life experiences for patients with this syndrome.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Must be diagnosed with Hereditary Multiple Exostoses

  • Adult patients or parents of child patients

Study Design

Total Participants: 200
Study Start date:
May 01, 2007
Estimated Completion Date:
February 28, 2014

Study Description

At the time of recruitment, subjects will be asked to indicate whether they would like to participate in a one-time survey, or are willing to participate in the initial survey plus two additional questionnaire administrations, thereafter, which will be used to develop the disease-specific quality of life (QOL) score. All participants will complete either the SF-36 survey (for adult HME subjects) or the CHQ PF (for parents of children with HME), as applicable, in addition to a blank form with categorical subheadings (such as recreation, social function, etc.), which they will use to address any issues not covered in the standardized questionnaire. Standardized questionnaires will be scored and analyzed. The items listed on the second form will be compiled and reapplied to subjects that indicated interest in extended participation in survey completion. Subjects will be asked to determine which items apply to them and to rank these applicable items in order of importance. The results from this will be used to develop a 30 question, disease-specific questionnaire. The final step will be to readminister this survey, in conjunction with the SF-36 or CHQ PF, and follow up, in two weeks, with a second administration of the aforementioned surveys, in order to test the variability and validity of the disease-specific, health-related, quality of life score.

Connect with a study center

  • BC Children's Hospital

    Vancouver, British Columbia V6H 3V4
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.